Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Digital twin industrial technology and manufacturing automation technology. 3d illustration | Image Credit: ©photon_photo -stock.adobe.com

Using Automation to Enhance Pharmaceutical Manufacturing

ByRahul Mittal

July 13th 2026

Munnik Revisits His 2026 Predictions: A Midyear Check-In on Regulatory Reform, Data, and AI in Pharma

ByRemco Munnik,Christopher Cole

July 13th 2026

Dostarlimab monotherapy achieves strong clinical data from Phase II trial

Can Dostarlimab Replace Surgery for dMMR/MSI-H Rectal Cancer?

ByZachary Zubulake

July 13th 2026

A top view of medicine powders, liquids in containers, and various manufactured medicine on the American flag. An America pharmaceuticals concept. | image Credit: ©Ming -stock.adobe.com

The FDA Moves to Modernize Drug Manufacturing Registration

BySusan Haigney

July 10th 2026

Sarclisa Escena is subcutaneous injection designed for 3 multiple myeloma treatment combinations

The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma

ByZachary Zubulake

July 10th 2026

June 2003

Articles in this issue

Related Content

Using Automation to Enhance Pharmaceutical Manufacturing

Munnik Revisits His 2026 Predictions: A Midyear Check-In on Regulatory Reform, Data, and AI in Pharma

Can Dostarlimab Replace Surgery for dMMR/MSI-H Rectal Cancer?

The FDA Moves to Modernize Drug Manufacturing Registration

The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma

Trending on Pharmaceutical Technology

Using Automation to Enhance Pharmaceutical Manufacturing

Regulatory Actions Impacting Biologics

Munnik Revisits His 2026 Predictions: A Midyear Check-In on Regulatory Reform, Data, and AI in Pharma

The FDA Moves to Modernize Drug Manufacturing Registration

Can Dostarlimab Replace Surgery for dMMR/MSI-H Rectal Cancer?